1Cannon CP.The IDEAL cholesterol:lower is better[].JAMA.2005 被引量：1
2Cannon CP,Braunwald E,M cCabe CH,et al.Pravastatin or Atorvastatin Evaluation and Infection Therapy-Throm bolysis in M yocardial Infarction22Investigators.Intensive versus m oderate lipid lowering with statins after acute coronary syndrom es[].N EnglJ M ed.2004 被引量：1
3LaRosa JC,Grundy SM,W aters DD,etal.Treating to New Targets(TNT)Investigators.Intensive lower-ing with atorvastatin in patients with stable coronary disease[].N EnglJ M ed.2005 被引量：1
4Grundy SM,Cleem an JI,Bairey M erz CN,etal.for the Coordinating Com m ittee ofthe NationalCholesterol Education Program.Im plications of recent clinical trials for the National Cholesterol Education Program Adult Treatm ent Panel III guidelines[].Circulation.2004 被引量：1
5Pedersen TR,Faergem an O,Kastelein JJP,etal.the Increm ental Decrease in Events through Aggressive Lipid Lowering(IDEAL)Study Group.H igh-dose atorvastatin vs usual-dose sim vastatin for secondary prevention after m yocardial infarction.The IDEAL study:a random ized controlled trial[].JAMA.2005 被引量：1
